Literature DB >> 8305187

Depression in Alzheimer patients: discrepancies between patient and caregiver reports.

J Moye1, W N Robiner, T B Mackenzie.   

Abstract

Estimates of the prevalence of depression in dementia patients vary widely. One problem in accurate identification of such depression is determining whether to rely on demented patients' reports or second-party caregivers' reports of symptoms. To further explore this problem, 31 outpatients with probable Alzheimer disease and their 31 caregivers were interviewed separately with depressive symptom questionnaires. Caregivers reported more depressive symptoms in dementia patients than patients reported for themselves. Correlations between caregivers' and patients' reports of individual symptoms ranged between -0.23 to 0.76, with lowest correlations found for intrapsychic distress, cognitive impairment, and hallucinations. Patients' responses were not necessarily affected by stereotypic responding or severity of impairment, but patients appeared to under-report symptomatology. Caregivers' responses were associated with the extent of contact with the patients, familial relationship, and sources of information used to determine patients' mood but were not correlated with caregivers' depression or ratings of how they would feel if they were "in the patient's shoes."

Entities:  

Mesh:

Year:  1993        PMID: 8305187     DOI: 10.1097/00002093-199307040-00001

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  2 in total

1.  Self-, collateral- and clinician assessment of depression in persons with cognitive impairment.

Authors:  Mohit P Chopra; Jan R Sullivan; Zachary Feldman; Reid D Landes; Cornelia Beck
Journal:  Aging Ment Health       Date:  2008-11       Impact factor: 3.658

2.  Field-testing phase of the development of individual cognitive stimulation therapy (iCST) for dementia.

Authors:  Lauren A Yates; Vasiliki Orgeta; Phuong Leung; Aimee Spector; Martin Orrell
Journal:  BMC Health Serv Res       Date:  2016-07-08       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.